These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22609259)

  • 41. Estimation of residual glomerular filtration rate in peritoneal dialysis patients using cystatin C: comparison with 51Cr-EDTA clearance.
    Carter JL; Lane CE; Fan SL; Lamb EJ
    Nephrol Dial Transplant; 2011 Nov; 26(11):3729-32. PubMed ID: 21441400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Underestimation of urinary albumin to creatinine ratio in morbidly obese subjects due to high urinary creatinine excretion.
    Guidone C; Gniuli D; Castagneto-Gissey L; Leccesi L; Arrighi E; Iaconelli A; Mingrone G
    Clin Nutr; 2012 Apr; 31(2):212-6. PubMed ID: 22030400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between serum cystatin C, monocytes and other inflammatory markers.
    Evangelopoulos AA; Vallianou NG; Bountziouka V; Katsagoni C; Bathrellou E; Vogiatzakis ED; Bonou MS; Barbetseas J; Avgerinos PC; Panagiotakos DB
    Intern Med J; 2012 May; 42(5):517-22. PubMed ID: 21470355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical value of the determination of markers for endothelial dysfunction (endothelin-1, microalbuminuria) and tubulointerstitial tissue lesion (β2-microglobulin, monocyte chemotactic protein-1) in hypertensive patients with uric acid metabolic disorders].
    Stakhova TIu; Shcherbak AV; Kozlovskaia LV; Taranova MV; Balkarov IM
    Ter Arkh; 2014; 86(6):45-51. PubMed ID: 25095655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utility of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations in obese diabetic individuals before and after weight loss.
    Jesudason D; Pedersen E; Clifton P
    Am J Kidney Dis; 2014 Jul; 64(1):159-61. PubMed ID: 24685063
    [No Abstract]   [Full Text] [Related]  

  • 46. Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.
    Chen YM; Lin SL; Chiang WC; Wu KD; Tsai TJ
    Kidney Int; 2006 Apr; 69(8):1410-5. PubMed ID: 16541021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary and circulating levels of the anti-angiogenic isoform of vascular endothelial growth factor-A in patients with chronic kidney disease.
    Kikuchi R; Yasuda Y; Nakatochi M; Shibata Y; Hara T; Suzuki A; Imaizumi T; Suzuki S; Ishii H; Takeshita K; Matsushita T; Maruyama S; Murohara T
    Clin Chim Acta; 2017 Dec; 475():102-108. PubMed ID: 29055691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between urinary sodium, creatinine, albumin, and long-term survival in chronic kidney disease.
    McQuarrie EP; Traynor JP; Taylor AH; Freel EM; Fox JG; Jardine AG; Mark PB
    Hypertension; 2014 Jul; 64(1):111-7. PubMed ID: 24732890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic kidney disease in type 2 diabetes patients.
    Siddiqui K; Joy SS; Al-Rubeaan K
    Int Urol Nephrol; 2019 Aug; 51(8):1379-1386. PubMed ID: 31250339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease.
    Eardley KS; Zehnder D; Quinkler M; Lepenies J; Bates RL; Savage CO; Howie AJ; Adu D; Cockwell P
    Kidney Int; 2006 Apr; 69(7):1189-97. PubMed ID: 16609683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum cystatin C in relation to fat mass loss after bariatric surgery.
    Sledziński T; Proczko-Markuszewska M; Kaska L; Stefaniak T; Swierczyński J
    Pol Przegl Chir; 2012 Apr; 84(4):202-7. PubMed ID: 22698658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.
    Gregg LP; Tio MC; Li X; Adams-Huet B; de Lemos JA; Hedayati SS
    Am J Nephrol; 2018; 47(6):395-405. PubMed ID: 29874658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases.
    Vianna HR; Soares CM; Silveira KD; Elmiro GS; Mendes PM; de Sousa Tavares M; Teixeira MM; Miranda DM; Simões E Silva AC
    Pediatr Nephrol; 2013 Mar; 28(3):463-9. PubMed ID: 23161207
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
    Camilla R; Brachemi S; Pichette V; Cartier P; Laforest-Renald A; MacRae T; Madore F; Troyanov S
    J Nephrol; 2011; 24(1):60-7. PubMed ID: 20437404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased urinary cystatin C indicated higher risk of cardiovascular death in a community cohort.
    Helmersson-Karlqvist J; Ärnlöv J; Carlsson AC; Härmä J; Larsson A
    Atherosclerosis; 2014 May; 234(1):108-13. PubMed ID: 24637410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin resistance is a risk factor for the progression of chronic kidney disease.
    Kobayashi H; Tokudome G; Hara Y; Sugano N; Endo S; Suetsugu Y; Kuriyama S; Hosoya T
    Clin Nephrol; 2009 Jun; 71(6):643-51. PubMed ID: 19473633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of serum adiponectin level with albuminuria in chronic kidney disease patients.
    Kim HY; Bae EH; Ma SK; Chae DW; Choi KH; Kim YS; Hwang YH; Ahn C; Kim SW
    Clin Exp Nephrol; 2016 Jun; 20(3):443-9. PubMed ID: 26445954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ghrelin Levels and Decreased Kidney Function in Patients with Early Stages of Chronic Kidney Disease Against the Background of Obesity.
    Gubina NV; Kupnovytska IH; Mishchuk VH; Markiv HD
    J Med Life; 2020; 13(4):530-535. PubMed ID: 33456602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction.
    Ebert T; Hopf LM; Wurst U; Bachmann A; Kralisch S; Lössner U; Platz M; Kratzsch J; Stolzenburg JU; Dietel A; Grisk O; Beige J; Anders M; Bast I; Klöting N; Blüher M; Stumvoll M; Fasshauer M
    Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1027-34. PubMed ID: 24813306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implications for kidney disease in obese children and adolescents.
    Savino A; Pelliccia P; Giannini C; de Giorgis T; Cataldo I; Chiarelli F; Mohn A
    Pediatr Nephrol; 2011 May; 26(5):749-58. PubMed ID: 21308381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.